Study characteristics |
Methods |
Single‐blind, randomized, placebo‐controlled |
Participants |
On‐pump CABG only |
Interventions |
Magnesium vs. placebo |
Outcomes |
AF |
Follow‐Up |
10 days |
Concurrent Antiarrhythmic Medications |
Metoprolol (25‐50 mg tid), Digoxin |
Notes |
|
Risk of bias |
Bias |
Authors' judgement |
Support for judgement |
Random sequence generation (selection bias) |
Unclear risk |
Randomization methods not described |
Allocation concealment (selection bias) |
Unclear risk |
Concealment methods not described |
Blinding of participants and personnel (performance bias)
All outcomes |
Low risk |
Placebo‐controlled |
Blinding of outcome assessment (detection bias)
All outcomes |
Unclear risk |
Blinding not described |
Incomplete outcome data (attrition bias)
All outcomes |
Unclear risk |
Not addressed |
Selective reporting (reporting bias) |
Unclear risk |
Protocol not available |
Intention‐to‐treat analysis |
Unclear risk |
Not reported |